What We Do
Our innovative thinking and strategic advice helps clients in the payer, provider, digital health, and life sciences sectors realize their most ambitious organizational and operational visions by bridging the gap between their business today and their vision for the future.
At Oliver Wyman, we are focused on creating positive change in healthcare, but we know we can’t do it all ourselves. Together, with today's leading healthcare experts and innovators, we’ve built a community to share and shape ideas that will transform healthcare. We work to ensure industry transformation through generating meaningful client impact, delivering strategic insights, and creating a healthcare system that meets the needs of communities and companies.
On November 1, 2021, the Huron life sciences strategy consulting team joined Oliver Wyman, allowing us to bring our relentless pursuit of a better way to pharmaceutical, biotechnology, and medical device companies. Our new colleagues bring the expertise needed to help life sciences companies tackle their most pressing strategic questions, including increasingly complex commercialization and access-related issues.
What We Think
Health Innovation Journal Volume 6
A new set of norms and expectations are challenging leaders to break away from the status quo.Read more
Healthcare CEO Agenda For 2023
Healthcare needs bold mission-oriented leaders who are willing to put their own careers on the line to reshape the industry.Read more
5 Areas That Will Shape Healthcare in 2023
After three years of upheaval, 2023 may be the year when the healthcare industry regains its footing.Read more
Why Is IT Holding Us Hostage?
Despite advances, healthcare has yet to realize the full promise of digital tools.Read more
How Pharma Can Achieve Net Zero Goals
Pharmaceutical companies are making bold pledges to reduce their carbon footprints. Getting there means overcoming some significant hurdles.Read more
The Case For Partnering With Your Competitors
From a potential recession to growing cost pressures, insurers face a host of uncertainties this year. One way to ease the pain is to take a cue from other industries and partner with competitors.Read more
A Personalized Model For Primary Care
Primary care must evolve to better meet patient needs and improve the patient experience.Read more
Closing The Gender Health Gap
Pharma’s opportunity to move the needle on closing the gender health gap.Read more
Who We Are
Sam Glick Global Leader of Health and Life Sciences
Chris Bernene Partner and Americas Health Leader
Dr. Sven-Olaf Vathje Partner and Head of HLS IMEA
Andreas Eggert Partner and Head of HLS Europe
Martin Graf Partner and Government Services Leader
Shivani Shah Executive Director and Health Innovation Center Leader
Marcia Macphearson Partner and Affordability and Quality Impact Leader
Deirdre Baggot Partner and Private Capital Leader
Minoo Javanmardian, PhD Partner and Provider Transformation Leader
There is immense pressure across the entire healthcare landscape to provide higher quality care, improve the patient experience, lower costs, and reduce clinician burnout. Our Affordability and Quality Impact practice has deep expertise across lines of business to help organizations identify cost drivers, find efficiencies, improve quality of care, and more.